NL-OMON20165已完成不适用
MMR vaccine given to 14 month old children, administered subcutaneously versus intramuscularly.
ational Institute for Public Health and the Environment (RIVM)0 个研究点目标入组 67 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 67
研究概览
简要总结
AB Lafeber et al. RIVM report 000002 001, sep. 2001
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Children aged 12 to 18 months in good general health.
排除标准
- •1. Proven allergy for any of the vaccine components;
- •2. Contraindication for MMR vaccination (e.g. administration of blood products within 3 months before MMR vaccination);
研究者
相似试验
已完成
不适用
Measles, mumps and rubella vaccine given to 14 month old children, administered subcutaneously versus intramuscularlyMeasles Mumps Rubella (MMR) vaccinationInfections and InfestationsMMR vaccinationISRCTN61378987ational Institute of Public Health and Environmental Protection (RIVM) (The Netherlands)67
已完成
2 期
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™MeaslesVaricellaMumpsRubellaNCT00353288GlaxoSmithKline446
已完成
2 期
Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™MeaslesRubellaVaricellaMumpsNCT00352898GlaxoSmithKline400
尚未招募
3 期
The effect of MMR vaccine in preventing Covid disease 19IRCT20200802048266N1Ahvaz University of Medical Sciences323
已完成
3 期
Intralesional measles, mumps, rubella (MMR) vaccine versus tuberculin purified protein derivative (PPD) in the treatment of palmoplantar and periungual warts: A randomized controlled trialClearance of wartswarts , tuberculin purified protein derivative (PPD), measles, mumps, rubella (MMR) vaccine , intralesionalTCTR20200604014Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital40